# US 2026/0265230 A1 · Fluorescent and self-assembling ureidopyrimidinone conjugates and preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0265230 A1
- Document ID: US20260265230A1
- Status: Published application
- Kind: A1
- Application number: 18/724,997
- Filed: 2023-02-07
- Published: 2026-09-10
- Earliest claimed: 2022-02-07
- Assignees: Council of Scientific and Industrial Research An Indian Registered Body Incorpor
- Applicants: Council of Scientific and Industrial Research An Indian Registered Body Incorpor
- Inventors: Rashid P P; Gangadhar Jessy SANJAYAN
- Web page: https://patentgrep.com/patent/US20260265230A1

## CPC

- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C09B 57/00: Other synthetic dyes of known constitution
- C07D 239/47: One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- C09B 57/02: Coumarine dyes
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to fluorescent and self-assembling ureidopyrimidinones conjugates of formula (I). The present invention further relates to the process for preparation of compounds of Formula (I). The coumarin and hydroquinone conjugates of formula (I) are useful for inducing peptide/protein assembly and recognition, and also to modulate protein/peptide secondary and tertiary structures

## Claims

### Claim 1

A fluorescent and self-assembling ureidopyrimidinone compound of formula (I)
wherein:
R1 represents
R2 is selected from (un)substituted C1-C6 alkyl, (un)substituted aryl, (un)substituted natural amino acids which may be protected, (—CH2)n-CH—(NH2)(COOH), protected (—CH2)n-CH—(NH2)(COOH), linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines; wherein n is 1-5; and
R3 and R4 are independently selected from (un)substituted C1-C6 alkyl, (un)substituted aryl, (un)substituted natural amino acids which may be protected, linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines;
provided that at least one of R2 or R3 recite (—CH2)n-CH—(NH2)(COOH), protected (—CH2)n-CH—(NH2)(COOH), (un)substituted natural amino acids which may be protected, linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines.

### Claim 2 (depends on 1)

The compound as claimed in claim 1, wherein R1 is 7-diethylamino-2-oxo-2H-chromen-3-yl or 1,4-dimethoxy phenyl.

### Claim 3 (depends on 1)

The compound as claimed in claim 1, wherein R2 is (un)substituted natural amino acids which may be protected and linear or branched (un)substituted C1-C6 amines.

### Claim 4 (depends on 1)

The compound as claimed in claim 1, wherein the amino acid is selected from lysine, alanine, leucine, valine, phenylalanine, or combinations thereof.

### Claim 5 (depends on 1)

The compound as claimed in claim 1, wherein the compound of formula (I) is selected from the group consisting of:
i. N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl) carbamoyl) lysine (1);
ii. N6-((6-(2,5-dimethoxyphenyl)-4-oxo-1,4-dihydropyrimidin-2-yl)carbamoyl)lysine (2);
iii. N2-(tert-butoxycarbonyl)-N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysine (6);
iv. N2-(tert-butoxycarbonyl)-N6-((6-(2,5-dimethoxyphenyl)-4-oxo-1,4-dihydropyrimidin-2-yl)carbamoyl)lysine (10);
v. Methyl N2-(tert-butoxycarbonyl)-N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylleucinate (11);
vi. Methyl N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylleucinate (12);
vii. Methyl N2-((tert-butoxycarbonyl)alanyl)-N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylleucinate (13);
viii. Methyl N2-(tert-butoxycarbonyl)-N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylalanylleucinate (14);
ix. Methyl N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylalanylleucinate (15); and
x. Methyl N2-(tert-butoxycarbonyl)phenylalanylvalyl-N6-((4-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-6-oxo-1,6-dihydropyrimidin-2-yl)carbamoyl)lysylalanylleucinate (16).

### Claim 6

A process for synthesis of fluorescent and self-assembling ureidopyrimidinone compound, the process comprising the steps of:
a) reacting compound of formula 4′ with carbonyldiimidazole (CDI) in a solvent to obtain the intermediate of formula 5′;
b) reacting the intermediate of formula 5′ as obtained in step (a) with Na-Boc-protected amino acid (Na-Boc-L-lysine) in presence of base in solvent to obtain BOC-protected compound of formula 6′;
c) deprotecting the compound of formula 6′ as obtained in step (a) by using equal proportion of TFA and DCM to obtain the compound of formula (I);
wherein:
R1 represents
R2 is selected from (un)substituted C1-C6 alkyl, (un)substituted aryl, (un)substituted natural amino acids which may be protected, (—CH2)n-CH—(NH2)(COOH), protected (—CH2)n-CH—(NH2)(COOH), linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines; wherein n is 1-5; and
R3 and R4 are independently selected from (un)substituted C1-C6 alkyl, (un)substituted aryl, (un)substituted natural amino acids which may be protected, linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines;
provided that at least one of R2 or R3 recite (—CH2)n-CH—(NH2)(COOH), protected (—CH2)n-CH—(NH2)(COOH), (un)substituted natural amino acids which may be protected, linear or branched (un)substituted C1-C6 alcohols, or linear or branched (un)substituted C1-C6 amines.

### Claim 7 (depends on 6)

The process as claimed in claim 6, wherein the solvent is selected from polar or non-polar, or protic or aprotic solvents.

### Claim 8 (depends on 6)

The process as claimed in claim 6, wherein the solvent is selected from dimethyl sulfoxide, lower alcohols, nitriles, ketones, halogenated hydrocarbons, trifluoro acetic acid(TFA), or combinations thereof.

### Claim 9 (depends on 6)

The process as claimed in claim 6, wherein the base is selected from ethylamine, triethylamine, N,N-diisopropylethylamine(DIPEA), pyridine, sodium hydroxide, alkali or alkaline earth metal carbonates, alkali or alkaline earth metal bicarbonates, or combinations thereof.

### Claim 10 (depends on 6)

The process as claimed in claim 6, wherein the process further comprises a step of incorporating the compound of formula (I) into peptides by reacting the compound of formula (I) with amino acids using a coupling reagent, wherein the coupling reagent is hexafluorophosphate benzotriazoletetramethyluronium (HBTU).
